D. Portalez

1.9k total citations
34 papers, 626 citations indexed

About

D. Portalez is a scholar working on Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Rheumatology. According to data from OpenAlex, D. Portalez has authored 34 papers receiving a total of 626 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Pulmonary and Respiratory Medicine, 14 papers in Radiology, Nuclear Medicine and Imaging and 9 papers in Rheumatology. Recurrent topics in D. Portalez's work include Prostate Cancer Diagnosis and Treatment (23 papers), Prostate Cancer Treatment and Research (17 papers) and MRI in cancer diagnosis (10 papers). D. Portalez is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (23 papers), Prostate Cancer Treatment and Research (17 papers) and MRI in cancer diagnosis (10 papers). D. Portalez collaborates with scholars based in France, Belgium and United States. D. Portalez's co-authors include Bernard Malavaud, R. Renard-Penna, F. Cornud, Vincent Misraï, É. Bruguière, Pierre Mozer, Nicolas Barry Delongchamps, M. Thoulouzan, M. Roumiguié and Guillaume Ploussard and has published in prestigious journals such as Radiology, The Journal of Urology and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

D. Portalez

29 papers receiving 619 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
D. Portalez France	12	567	245	241	59	40	34	626
Sonia Gaur United States	13	735 1.3×	327 1.3×	266 1.1×	60 1.0×	33 0.8×	22	807
Dmitry Volkin United States	10	433 0.8×	177 0.7×	198 0.8×	80 1.4×	36 0.9×	15	519
Mohamed Abd-Alazeez United Kingdom	8	479 0.8×	217 0.9×	191 0.8×	38 0.6×	29 0.7×	9	514
Olivier Wegelin Netherlands	6	602 1.1×	195 0.8×	255 1.1×	83 1.4×	61 1.5×	13	626
Walter Taubenslag United States	7	458 0.8×	99 0.4×	207 0.9×	91 1.5×	47 1.2×	8	485
Hugo Andreini United States	7	463 0.8×	99 0.4×	210 0.9×	92 1.6×	47 1.2×	9	491
Marcin Czarniecki United States	14	510 0.9×	317 1.3×	165 0.7×	60 1.0×	22 0.6×	23	636
Francesca Mertan United States	15	867 1.5×	495 2.0×	284 1.2×	62 1.1×	38 0.9×	21	968
S. White United States	6	498 0.9×	405 1.7×	260 1.1×	126 2.1×	24 0.6×	7	750
Anthony V. D’Amico United States	13	526 0.9×	98 0.4×	168 0.7×	77 1.3×	27 0.7×	22	594

Countries citing papers authored by D. Portalez

Since Specialization

Citations

This map shows the geographic impact of D. Portalez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Portalez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Portalez more than expected).

Fields of papers citing papers by D. Portalez

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Portalez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Portalez. The network helps show where D. Portalez may publish in the future.

Co-authorship network of co-authors of D. Portalez

This figure shows the co-authorship network connecting the top 25 collaborators of D. Portalez. A scholar is included among the top collaborators of D. Portalez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Portalez. D. Portalez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Péricart, Sarah, R. Aziza, D. Portalez, et al.. (2023). Significant prostate cancer risk after MRI-guided biopsy showing benign findings: Results from a cohort of 381 men. PubMed. 34(1). 102547–102547.

Péricart, Sarah, R. Aziza, D. Portalez, et al.. (2021). Managing Discordant Findings Between Multiparametric Magnetic Resonance Imaging and Transrectal Magnetic Resonance Imaging–directed Prostate Biopsy—The Key Role of Magnetic Resonance Imaging–directed Transperineal Biopsy. European Urology Oncology. 5(3). 296–303. 5 indexed citations

Ploussard, Guillaume, Jean‐Baptiste Beauval, Raphaële Renard‐Penna, et al.. (2020). Assessment of the Minimal Targeted Biopsy Core Number per MRI Lesion for Improving Prostate Cancer Grading Prediction. Journal of Clinical Medicine. 9(1). 225–225. 36 indexed citations

Ploussard, Guillaume, Jean‐Baptiste Beauval, M. Lesourd, et al.. (2019). Active surveillance eligibility of MRI-positive patients with grade group 2 prostate cancer: a pathological study. World Journal of Urology. 38(7). 1735–1740. 5 indexed citations

Ploussard, Guillaume, Jean‐Baptiste Beauval, M. Lesourd, et al.. (2019). Impact of MRI and Targeted Biopsies on Eligibility and Disease Reclassification in MRI-positive Candidates for Active Surveillance on Systematic Biopsies. Urology. 137. 126–132. 9 indexed citations

Ploussard, Guillaume, Jean‐Baptiste Beauval, M. Lesourd, et al.. (2019). Performance of systematic, MRI-targeted biopsies alone or in combination for the prediction of unfavourable disease in MRI-positive low-risk prostate cancer patients eligible for active surveillance. World Journal of Urology. 38(3). 663–671. 9 indexed citations

Roumiguié, M., P. Gräff, Jonathan Khalifa, et al.. (2018). Refining the risk-stratification of transrectal biopsy-detected prostate cancer by elastic fusion registration transperineal biopsies. World Journal of Urology. 37(2). 269–275. 12 indexed citations

Gräff, P., D. Portalez, Amélie Lusque, et al.. (2018). IDEAL 2a Phase II Study of Ultrafocal Brachytherapy for Low- and Intermediate-risk Prostate Cancer. International Journal of Radiation Oncology*Biology*Physics. 102(4). 903–911. 21 indexed citations

Malavaud, Bernard, X. Gamé, Jean‐Baptiste Beauval, et al.. (2016). MRI evaluation following partial HIFU therapy for localized prostate cancer: A single-center study. Progrès en Urologie. 26(9). 517–523. 12 indexed citations

10.

Delongchamps, Nicolas Barry, D. Portalez, É. Bruguière, et al.. (2015). Trois biopsies ciblées par fusion d’image IRM – échographie sont-elles suffisantes pour diagnostiquer un cancer de la prostate en présence d’une image IRM prostatique suspecte et isolée ? Résultats de l’étude prospective multicentrique MURIELLE. Progrès en Urologie. 25(13). 831–831.

11.

Renard-Penna, R., Pierre Mozer, F. Cornud, et al.. (2015). Prostate Imaging Reporting and Data System and Likert Scoring System: Multiparametric MR Imaging Validation Study to Screen Patients for Initial Biopsy. Radiology. 275(2). 458–468. 81 indexed citations

12.

Cornud, F., Nicolas Barry Delongchamps, D. Portalez, et al.. (2013). TRUS–MRI image registration: a paradigm shift in the diagnosis of significant prostate cancer. Abdominal Imaging. 38(6). 1447–1463. 47 indexed citations

13.

Misraï, Vincent, et al.. (2013). Traitement de l’hyperplasie bénigne de prostate par photovaporisation au laser Greenlight XPS© : analyse de la courbe d’apprentissage et apport de l’échographie endorectale peropératoire. Progrès en Urologie. 23(10). 869–876. 9 indexed citations

14.

Portalez, D., et al.. (2012). Validation of the European Society of Urogenital Radiology Scoring System for Prostate Cancer Diagnosis on Multiparametric Magnetic Resonance Imaging in a Cohort of Repeat Biopsy Patients. European Urology. 62(6). 986–996. 150 indexed citations

15.

Portalez, D., et al.. (2010). Prospective comparison of T2w-MRI and dynamic-contrast-enhanced MRI, 3D-MR spectroscopic imaging or diffusion-weighted MRI in repeat TRUS-guided biopsies. European Radiology. 20(12). 2781–2790. 45 indexed citations

16.

Cornud, F., Frédéric Lecouvet, & D. Portalez. (2010). Impact de l’IRM sur la prise en charge d’un cancer de prostate. DIAL (Catholic University of Leuven). 20(1). F13–F20.

17.

Cornud, F., M.F. Bellin, & D. Portalez. (2006). IRM et bilan d’extension du cancer de la prostate. Journal de Radiologie. 87(2). 228–241. 8 indexed citations

18.

Bleuzen, A., et al.. (2006). Role of parametric imaging in contrast-enhanced sonography of hepatic focal nodular hyperplasia. Journal of Clinical Ultrasound. 34(8). 367–373. 6 indexed citations

19.

Portalez, D., et al.. (2004). Détection du cancer de la prostate par IRM endorectale dynamique et spectroscopique-proton. Journal de Radiologie. 85(12). 1999–2004. 11 indexed citations

20.

Portalez, D., et al.. (2001). Trans-rectal ultrasonography (TRUS) with lipiodol injection for localization of the prostatic apex before radiotherapy planning. Radiotherapy and Oncology. 61(2). 135–141. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact